首页> 外国专利> Monoclonal analogue bodies MZ versus Ganglioside GD, MZ producing cells and MZ containing agent.

Monoclonal analogue bodies MZ versus Ganglioside GD, MZ producing cells and MZ containing agent.

机译:单克隆类似物MZ与神经节苷脂GD,产生MZ的细胞和含有MZ的试剂。

摘要

Disclosed is a novel anti-ganglioside GD1a monoclonal antibody (MZ) which is capable of recognizing ganglioside GD1a but is practically incapable of recognizing GalCer, LacCer, Gb3, Gb4, GA1, GA2, GM1, GM2, GM3, GD1b, GT1b, GQ1b, Fuc-GM1, nLc4 and sialosyl nLc4; MZ-producing cells; an MZ-containing reagent; and a method for the detection or quantification of GD1a using the reagent, e.g., to diagnose cancer, systematic lupus erythematosus and diseases resulting from organic injury of the nervous system.
机译:公开了一种新型的抗神经节苷脂GD1a单克隆抗体(MZ),该抗体能够识别神经节苷脂GD1a,但实际上不能识别GalCer,LacCer,Gb3,Gb4,GA1,GA2,GM1,GM2,GM3,GD1b,GT1b,GQ1b, Fuc-GM1,nLc4和唾液酸基nLc4;产生MZ的细胞;含MZ的试剂;以及使用该试剂检测或定量GD1a的方法,例如,用于诊断癌症,系统性红斑狼疮和神经系统器质性损伤所致疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号